12:39 PM EST, 01/30/2025 (MT Newswires) -- Bausch Health Companies ( BHC ) will report its fourth-quarter results after market close on Feb. 19.

RBC is forecasting fourth-quarter revenue of US$2.56 billion (vs. FactSet consensus of US$2.52 billion) and adj. EBITDA of US$919 million (vs. FactSet consensus US$939 million).

Analyst Douglas Miehm expects the focus to be on 2025 guidance, upcoming debt maturities in Q4/25 ($2,215 million), and the potential full separation of Bausch + Lomb.

Target trimmed by US$1, to US$10, on Bausch + Lomb sale scenario weighting cut to 60% from 75%.

Maintain Sector Perform.

Price: 10.76, Change: -0.01, Percent Change: -0.09